News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
860,947 Results
Type
Article (87430)
Company Profile (760)
Press Release (772734)
Multimedia
Podcasts (172)
Webinars (28)
Section
Business (233053)
Career Advice (4139)
Deals (39795)
Drug Delivery (136)
Drug Development (91249)
Employer Resources (203)
FDA (18284)
Job Trends (17399)
News (397389)
Policy (39926)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (125)
Alliances (56979)
ALS (146)
Alzheimer's disease (1680)
Antibody-drug conjugate (ADC) (244)
Approvals (18308)
Artificial intelligence (489)
Autoimmune disease (75)
Automation (26)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (160)
Biotechnology (484)
Bladder cancer (132)
Brain cancer (52)
Breast cancer (503)
Cancer (3960)
Cardiovascular disease (339)
Career advice (3556)
Career pathing (38)
CAR-T (247)
CDC (57)
Cell therapy (683)
Cervical cancer (33)
Clinical research (75515)
Collaboration (1385)
Company closure (4)
Compensation (939)
Complete response letters (59)
COVID-19 (2956)
CRISPR (81)
C-suite (591)
Cystic fibrosis (135)
Data (4484)
Decentralized trials (2)
Denatured (61)
Depression (112)
Diabetes (454)
Diagnostics (7091)
Digital health (36)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (233)
Drug pricing (190)
Drug shortages (36)
Duchenne muscular dystrophy (203)
Earnings (98798)
Editorial (54)
Employer branding (25)
Employer resources (171)
Events (132996)
Executive appointments (991)
FDA (20749)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (14)
Funding (1256)
Gene editing (173)
Generative AI (48)
Gene therapy (546)
GLP-1 (1020)
Government (5384)
Grass and pollen (7)
Guidances (341)
Healthcare (20937)
HIV (48)
Huntington's disease (37)
IgA nephropathy (63)
Immunology and inflammation (242)
Immuno-oncology (20)
Indications (53)
Infectious disease (3197)
Inflammatory bowel disease (187)
Inflation Reduction Act (15)
Influenza (97)
Intellectual property (188)
Interviews (815)
IPO (17926)
IRA (59)
Job creations (5197)
Job search strategy (2865)
Kidney cancer (16)
Labor market (77)
Layoffs (640)
Leadership (33)
Legal (10148)
Liver cancer (91)
Longevity (12)
Lung cancer (572)
Lymphoma (265)
Machine learning (30)
Management (66)
Manufacturing (637)
MASH (140)
Medical device (14871)
Medtech (14894)
Mergers & acquisitions (22746)
Metabolic disorders (1156)
Multiple sclerosis (138)
NASH (23)
Neurodegenerative disease (227)
Neuropsychiatric disorders (60)
Neuroscience (2714)
NextGen: Class of 2025 (7687)
Non-profit (5096)
Now hiring (57)
Obesity (557)
Opinion (312)
Ovarian cancer (135)
Pain (166)
Pancreatic cancer (172)
Parkinson's disease (242)
Partnered (30)
Patents (417)
Patient recruitment (311)
Peanut (57)
People (66259)
Pharmaceutical (144)
Pharmacy benefit managers (27)
Phase I (23293)
Phase II (32778)
Phase III (24694)
Pipeline (2725)
Policy (295)
Postmarket research (3554)
Preclinical (10500)
Press Release (72)
Prostate cancer (201)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (672)
Real estate (7421)
Recruiting (78)
Regulatory (28016)
Reports (65)
Research institute (2689)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (71)
Schizophrenia (135)
Series A (207)
Series B (156)
Service/supplier (30)
Sickle cell disease (79)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4318)
State (2)
Stomach cancer (17)
Supply chain (100)
Tariffs (95)
The Weekly (109)
Vaccines (1047)
Venture capital (66)
Weight loss (396)
Women's health (58)
Worklife (21)
Date
Today (131)
Last 7 days (682)
Last 30 days (2538)
Last 365 days (33586)
2025 (26483)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1280)
Alabama (80)
Alaska (7)
Arizona (302)
Arkansas (14)
Asia (50975)
Australia (8959)
California (9454)
Canada (2857)
China (901)
Colorado (401)
Connecticut (422)
Delaware (271)
Europe (117115)
Florida (1393)
Georgia (316)
Hawaii (3)
Idaho (67)
Illinois (813)
India (51)
Indiana (461)
Iowa (19)
Japan (324)
Kansas (124)
Kentucky (38)
Louisiana (20)
Maine (78)
Maryland (1278)
Massachusetts (7120)
Michigan (314)
Minnesota (563)
Mississippi (4)
Missouri (119)
Montana (33)
Nebraska (26)
Nevada (108)
New Hampshire (77)
New Jersey (2628)
New Mexico (32)
New York (2577)
North Carolina (1410)
North Dakota (10)
Northern California (4275)
Ohio (297)
Oklahoma (22)
Oregon (50)
Pennsylvania (1966)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (49)
South Dakota (1)
Southern California (3614)
Tennessee (149)
Texas (1482)
United States (34977)
Utah (283)
Virginia (249)
Washington D.C. (83)
Washington State (818)
West Virginia (4)
Wisconsin (97)
Wyoming (1)
There are 860,947 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Altimmune to Present Phase 2b IMPACT Data on Pemvidutide in MASH in Late-Breaking Oral Podium Presentation and Late-Breaking Poster at AASLD The Liver Meeting® 2025
October 21, 2025
·
3 min read
Press Releases
Press Release: Sanofi’s Tzield accepted for expedited review in the US for stage 3 type 1 diabetes through FDA Commissioner’s National Priority Voucher pilot program
October 21, 2025
·
10 min read
Press Releases
Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline
October 21, 2025
·
3 min read
Press Releases
DRI Healthcare Trust Announces Acquisition of a Synthetic Royalty Interest in the U.S. Sales of Veligrotug and VRDN-003 for the Treatment of Thyroid Eye Disease (TED)
October 21, 2025
·
7 min read
Press Releases
Endo Launches First and Only Generic Version of RAVICTI® (glycerol phenylbutyrate) Oral Liquid in the United States
October 21, 2025
·
8 min read
Press Releases
Akebia Therapeutics Announces Five Presentations at ASN Kidney Week 2025
October 21, 2025
·
10 min read
Press Releases
IMUNON Hosts R&D Day Highlighting Progress on OVATION 3 Study in Pursuit of First Frontline Immunotherapy for Advanced Ovarian Cancer
October 21, 2025
·
5 min read
Press Releases
Primary Endpoint Met in EFTISARC-NEO Phase II Evaluating Neoadjuvant Efti in Soft Tissue Sarcoma and Data Presented at ESMO Congress 2025
October 21, 2025
·
5 min read
Press Releases
ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025
October 21, 2025
·
8 min read
Press Releases
Phathom Pharmaceuticals to Report Third Quarter 2025 Financial Results and Provide Business Update on Thursday, October 30, 2025
October 21, 2025
·
1 min read
1 of 86,095
Next
